Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy

Published:2020-02-27 Issue: Volume: Page:canres.2062.2019
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Tähtinen Siri,Feola Sara^ORCID,Capasso Cristian,Laustio Netta,Groeneveldt Christianne^ORCID,Ylösmäki Erkko O^ORCID,Ylösmäki Leena,Martins Beatriz,Fusciello Manlio,Medeot Marta,Tagliamonte Maria^ORCID,Chiaro Jacopo,Hamdan Firas,Peltonen Karita^ORCID,Ranki Tuuli,Buonaguro Luigi^ORCID,Cerullo Vincenzo^ORCID

Funder

EC | European Research Council

Orionin Tutkimussäätiö

Jane and Aatos foundation

Jalmari and Rauha Ahokas foundation

Maud Kuistila foundation

Helsinki Institute of Life science

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing the Antitumor Efficacy of Oncolytic Adenovirus Through Sonodynamic Therapy-Augmented Virus Replication;ACS Nano;2024-07-02

2. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy;Nature Protocols;2024-05-20

3. Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus;Frontiers in Immunology;2024-05-15

4. Intratumoral administration of mRNA-1273 vaccine delays melanoma growth in mice;2024-05-10

5. Engineering Microorganisms for Cancer Immunotherapy;Advanced Healthcare Materials;2024-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP